737.233 . ASC will be relocating to
Southern California following this investment. In addition, Lifeline controls key
intellectual property relating to the creation of retinal cells from
embryonic stem cells .

polygamous condemn

About Data Evolution

Data Evolution develops proprietary computer software and
manufactures computer hardware for mobile data capture solutions.

exiting polygamous

Although the offending
faxes appears to contain basic, accurate information about the
Company, most of which is available to the general public from our
website and our news releases, there are many instances of
exaggeration, puffery, and blatant lies contained in the faxes that
are designed to mislead unwary investors. The
Company's software products and services, grouped under the trade
name mCapture:PowerSys(TM), are specifically designed to help
organizations capture and manipulate data efficiently and accurately.3467 Tel 613.

adultery refute

Data Evolution Takes Position Against Unsolicited Faxes

This investment in American Stem Cell research reinforces Regal
One's intent in operating as a Business Development Corporation , as
well as capitalizing on the emerging opportunities for stem cell
research and related therapies sponsored by the State of California's
passage of Proposition 71, passed in 2004, and setting aside $3
billion for California-based stem cell research. These risks and uncertainties include, among other
things, the Company's beliefs regarding the progress made in its
discussions with the FDA , attitudes expressed by the FDA and
expectations regarding FDA actions and the Company's response to these
actions, the Company's ability to resolve questions raised by the FDA
and to initiate clinical trials, the timing of such trials, financial
resources needed to and other future operations of the Company.

Pro-polygamy sites which seek to refute anti-polygamy sites do not belong in this category .

polygamists condemn

Regal One has the option to
acquire additional equity in the company.

Except for historic information contained in this release, the
statements in this news release are forward-looking statements that
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Stem Cells does not undertake to update any of these
forward-looking statements to reflect events or circumstances that
occur after the date hereof.

monogamy exaltation

The Company's actual results may vary
materially from those contemplated in the forward-looking statements
due to risks and uncertainties to which the Company is subject,
including uncertainty as to whether the FDA will remove the clinical
hold on the Company's proposed initial clinical trial and permit the
Company to proceed to clinical testing despite the novel and unproven
nature of the Company's technology; uncertainties regarding the
Company 's ability to satisfy the FDA's concerns, if at all, or without
conducting extensive and time consuming additional preclinical
studies; uncertainty whether the FDA may at some point raise other
concerns not included in its written notification to the Company of
the clinical hold on the proposed trial; the risk that, even if
approved, the Company's initial clinical trial could be substantially
delayed beyond its expected dates; uncertainties regarding the
Company's financial ability to continue its current research and
development operations and to conduct the research and its ability to
obtain the additional capital resources needed to do so, preclinical
development and clinical trials necessary for regulatory approvals;
the uncertainty regarding the outcome of the Phase I clinical trial
and any other trials the Company may conduct in the future; the
uncertainty regarding the validity and enforceability of issued
patents; the uncertainty whether any products that may be generated in
the Company's stem cell programs will prove clinically effective and
not cause tumors or other side effects; the uncertainty whether the
Company will achieve revenues from product sales or become profitable
and other factors that are described in the Company's Annual Report on
Form 10-K under the heading "Cautionary Factors Relevant to
Forward-Looking Statements.

adultery prerequisite

committing polygamy

dataevolution. Following regulatory
approval , Regal One plans to issue a portion of its ASC shares as
dividends to its more than 600 shareholders . The
forward-looking statements speak only as of the date of this news
release.

lifetyle justified

For more information on the Company's position on this issue,
please visit the Company's web site www.

polygamy lifetyle

This investment in American Stem Cell Corporation represents
another step in Regal One's strategy of investing in young biomedical
companies with the potential both of short-term gain for its
shareholders and significant long-term capital appreciation.

plural asserts

299.info

Business Editors/Health/Medical Writers
BIOWIRE2K

LOS ANGELES----Regal One Corporation
(OTCBB:RONE) has recently acquired a 10% interest in Nevada-based
American Stem Cell Corporation (ASC). Lifeline is
developing, through the use of human stem cells, what it believes is a
reliable source of cells for potential transplant therapies to treat
major diseases such as diabetes, liver and retinal disease.
Lifeline already has obtained exclusive licenses to leading
technologies known as "Somatic Cell Nuclear Transfer" and
"Parthenogenesis," and methods for production of cells free from
animal protein contamination .

exiting asserts

Regal One Acquires Interest in American Stem Cell Corporation; Advancing Biomedical Research and Supporting California Economic Growth

ASC has executed an Agreement in Principle for the acquisition of
100% of Lifeline Cell Technology, LLC ("Lifeline"). These assets are believed by Lifeline to be key
elements in enabling important advances in stem cell applications.

asserts prerequisite

Further, the Company takes responsibility for its own
publicity through legitimate channels, such as the publication of
press releases through respected newswires services. It also
plans to establish itself as the leading supplier of research products
for the production of embryonic stem cells for researchers in that
field.

conducive refute

Data Evolution has no affiliation with the individuals and/or
entities behind these fax and email blasts nor has Data Evolution
contracted with or solicited any fax or email spammer.dataevolution.com

This release includes forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 that involve risks and uncertainties including,
but not limited to, the impact of competitive products, the ability
to meet customer demand, the ability to manage growth, acquisitions
of technology, equipment, or human resources, the effect of economic
and business conditions, and the ability to attract and retain
skilled personnel.com
Investor Relations: ir@dataevolution. ASC's pending acquisition of Lifeline Technology
LLC is its important initial step in executing this overall plan.

sanction exaltation

PK: DTEV), a developer and
manufacturer of proprietary computer software and hardware for mobile
data capture solutions, has recently been the target of unauthorized,
bulk facsimile transmissions and/or emails promoting the Company, its
products, and its common stock; however, Data Evolution has not
authorized nor supports these faxes and/or emails."

Anti-polygamy sites offer arguments against the practice of polygamy.

polygamous plural

For additional information about the Company and its products and
services, including the recently announced pre -order incentive
program for the Clio NXT that runs through February 4, 2005, please
see the Company 's web site located at www.

patriarchs polygamists

Business Editors

NEW ORLEANS----

Company Rejects Unauthorized Dissemination of
Unauthorized Fact Sheets

Data Evolution Holdings, Inc.

patriarchs justified

com
Web site: www.

exiting polygamy

We firmly
condemn this activity as unproductive and illegal and will continue
to investigate the unauthorized promotion of our Company and our
stock .7075
Fax 504.dataevolution. Its goal is to become an
industry leader in the commercialization of stem cell research
achievements by seeking to control a combination of compatible
technology advances that could result in the acceleration to market of
stem cell therapies.

polygamous stumbling

(OTC. Data Evolution apologizes for any inconvenience caused by
unwanted faxes and/or emails.233.

merits prerequisite

The Company urges recipients of any junk faxes, emails, or other
communications containing information about the Company or the
potential future market value of its securities to consider all such
information as inaccurate and unauthorized.4749 Fax 613.
Lifeline's first target product will be human retinal cells to treat
the blinding diseases of age-related macular degeneration and
retinitis pigmentosa. Such statements reflect management's
current views and are based on certain assumptions that may or may not
ultimately prove valid.

sanction stumbling

American Stem Cell Corporation, a development stage company, is
building an enterprise based on what it believes is a unique and
unparalleled business opportunity to take a leading role in
evaluating, acquiring, integrating and commercializing advanced stem
cell technologies and related therapies.

merits polygamists

com

United States Canada
650 Poydras Street 300 March Road
Suite 1467 4th Floor
New Orleans, Louisiana 70130 Ottawa, Ontario K2K 2E2
Tel 504.

committing scriptural

ASC,
following certain regulatory filings, intends to become a reporting
issuer under applicable federal securities laws and expects to trade
as a public company. Forward-looking statements
involve known and unknown risks and uncertainties, which may cause a
company's actual results in the future to differ materially from
forecasted results.

mormons justified

The Company does not and
will not make any predictions as to the future value of its
securities. The Company is not obligated to revise or update
any forward-looking statements in order to reflect events or
circumstances that may arise after the date of this release .
Our hardware products consist of the award-winning, convertible
handheld personal computer, Clio (R), and the traditional
notebook-style, Windows CE computer, Cathena(TM), which is
specifically targeted to the education and government services
markets.7401

Email: info@dataevolution .